Skip to main content

Table 4 Statin use in gastric cancer patients

From: Statins and the risk of gastric cancer in diabetes patients

Variables

Statin User

Non-Statin User

Pvalue

N

%

N

%

 

Sex

     

   Men

71

71.7

681

77.0

.2365

   Women

28

28.3

203

23.0

 

Lauren classification

     

   Intestinal

22

22.2

283

33.8

.1351

   Diffuse

67

67.7

518

61.9

 

   Mixed

4

4.0

36

4.3

 

   Missing information

6

6.0

47

5.3

 

Pathology

     

   W/D adenocarcinoma

26

26.3

142

16.0

.1461 (adenoca vs signet ring)

   M/D adenocarcinoma

39

39.4

357

40.3

   P/D adenocarcinoma

21

21.2

251

28.3

   Signet ring cell carcinoma

13

13.1

134

15.4

Smoking

     

   Never-smoker

51

51.5

391

44.2

.3037

   Smoker

47

47.5

472

53.4

 

   Missing information

1

1

21

2.4

 

Location

     

   Cardia

6

6.1

51

5.8

 

   Body ~ antrum

91

91.9

817

92.5

.9660

   Whole, multifocal

2

2.0

15

1.7

 

   Missing information

0

0

1

0.1

 

Helicobacter Pylori

     

   Present

44

44.4

331

37.4

.1897

   Absent

41

41.4

405

45.8

 

   Missing information

14

14.2

148

16.7

 

Stage

     

   Localized (stage I/II)

81

81.8

642

72.6

.0400

   Advanced (stage III/IV)

16

16.2

226

25.6

 

   Missing information

2

2.0

16

1.8

 
  1. *Abbreviations: W/D well differentiated, M/D moderately differentiated, P/D poorly differentiated.